Zydus Discovery DMCC Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Pennington New Jersey United States (1952)
Status: No NME R&D (1952)

Organization Overview

First Clinical Trial
2011
NCT01972893
First Marketed Drug
1992
minocycline (minocin)
First NDA Approval
2021
Fosdenopterin (Nulibry)
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ZYDUS | Zydus Discovery DMCC | ZYDUS HLTHCARE | ZYDUS LIFESCIENCES | Zydus Lifesciences Limited | Zydus lifesciences Limited (Formerly Cadila Healthcare Limited.) | ZYDUS NOVELTECH INC | ZYDUS PHARMS | ZYDUS PHARMS USA | ZYDUS PHARMS USA INC | Zydus Research Centre | Zydus Therapeutics Inc. | ZYDUS WORLDWIDE | Zydus Worldwide DMCC | ZYDUS WORLDWIDE DMCC